World Journal of Clinical Cases - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1815)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

122

WORD

HTML

914

Tables (1-3)

190

Sum=1286

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

134

Download

326

Sum=460

Jan 16, 2024 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Sun SS, Guo XD, Li WD, Chen JL. Lenvatinib combined with sintilimab plus transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma. World J Clin Cases 2024; 12(2): 285-292 [PMID: 38313649 DOI: 10.12998/wjcc.v12.i2.285]
URL:	https://www.wjgnet.com/2307-8960/full/v12/i2/285.htm

Number	Citing Articles
1	Feng Han, Xiao-Han Wang, Chen-Zhou Xu. Clinical benefits of transarterial chemoembolization combined with tyrosine kinase and immune checkpoint inhibitors for unresectable hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2024; 16(7): 3308-3320 doi: 10.4251/wjgo.v16.i7.3308 Abstract(153) \| Core Tip(157) \| Full Article(HTML)(502) \| Full Article with Cover (PDF)-6375K(38) \| Audio-5586K(8) \| Peer-Review Report-218K(16) \| Answering Reviewers-89K(17) \| Full Article (PDF)-6087K(46) \| Full Article (XML)-162K(21) \| Times Cited (0) \| Total Visits (1435) \| Open

Number

Citing Articles

Feng Han, Xiao-Han Wang, Chen-Zhou Xu. Clinical benefits of transarterial chemoembolization combined with tyrosine kinase and immune checkpoint inhibitors for unresectable hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2024; 16(7): 3308-3320 doi: 10.4251/wjgo.v16.i7.3308